ECLCX
Price
$28.68
Change
-$0.06 (-0.21%)
Updated
Jun 2 closing price
Net Assets
462.37M
RGAGX
Price
$88.82
Change
-$0.29 (-0.33%)
Updated
Jun 2 closing price
Net Assets
337.53B
Interact to see
Advertisement

ECLCX vs RGAGX

Header iconECLCX vs RGAGX Comparison
Open Charts ECLCX vs RGAGXBanner chart's image
ECLCX vs RGAGX Comparison Chart in %
View a ticker or compare two or three
VS
ECLCX vs. RGAGX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ECLCX is a Buy and RGAGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAGX has more cash in the bank: 338B vs. ECLCX (462M). RGAGX pays higher dividends than ECLCX: RGAGX (0.51) vs ECLCX (0.00). ECLCX was incepted earlier than RGAGX: ECLCX (24 years) vs RGAGX (17 years). ECLCX (1.79) is less costly to investors than RGAGX (0.29). RGAGX is a more actively managed with annual turnover of: 32.00 vs. ECLCX (20.00). RGAGX has a lower initial minimum investment than ECLCX: RGAGX (250) vs ECLCX (1000). RGAGX annual gain was more profitable for investors over the last year : 15.41 vs. ECLCX (0.07). RGAGX return over 5 years is better than : 27.14 vs. ECLCX (-4.49).
ECLCXRGAGXECLCX / RGAGX
Total Expense Ratio1.790.29617%
Annual Report Gross Expense Ratio1.790.29617%
Fund Existence24 years17 years-
Gain YTD8.86410.59984%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets462M338B0%
Annual Yield % from dividends0.000.51-
Returns for 1 year0.0715.410%
Returns for 3 years20.9155.3138%
Returns for 5 years-4.4927.14-17%
Returns for 10 years47.69117.0641%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CYAB0.670.04
+5.56%
Cyabra Inc.
VRSN297.410.82
+0.28%
VeriSign
NABL4.17-0.07
-1.65%
N-able
MMSI60.89-1.16
-1.87%
Merit Medical Systems
ANTX4.06-0.15
-3.56%
AN2 Therapeutics